Skip to content

Clinical trials

Phase 1 Congenital Abnormalities trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Phase: Phase 1 Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20028
20039
200415
200514
20067
20079
20087
20094
20105
20113
20125
20136
20143
20155
20171
20181
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Terminated23
Recruiting2
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)29
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
Fred Hutchinson Cancer Center6
Masonic Cancer Center, University of Minnesota4
Roswell Park Cancer Institute4
Case Comprehensive Cancer Center3
City of Hope Medical Center3
University of Medicine and Dentistry of New Jersey3
Vion Pharmaceuticals3
Alison Walker2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities115
Leukemia, Myeloid, Acute94
Precursor Cell Lymphoblastic Leukemia-Lymphoma61
Leukemia48
Blast Crisis38
Leukemia, Lymphocytic, Chronic, B-Cell37
Leukemia, Monocytic, Acute36
Leukemia, Erythroblastic, Acute35
Leukemia, Myelomonocytic, Acute35
Leukemia, Megakaryoblastic, Acute34

Trials

Showing 76 to 100 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.